Advertisement

Altered Homeostatic Adaptation of First- and Second-Phase β-Cell Secretion in the Offspring of Patients With Type 2 Diabetes

Studies With a Minimal Model to Assess β-Cell Function

  1. Riccardo C. Bonadonna1,
  2. Michael Stumvoll2,
  3. Andreas Fritsche2,
  4. Michele Muggeo1,
  5. Hans Häring2,
  6. Enzo Bonora1 and
  7. Timon W. van Haeften3
  1. 1Division of Endocrinology and Metabolic Diseases, University of Verona and Azienda Ospedaliera di Verona, Verona, Italy
  2. 2Medizinische Klinik, Abteilung für Endokrinologie, Stoffwechsel und Pathobiochemie, Eberhard-Karls-Universität, Tübingen, Germany
  3. 3Department of Internal Medicine, University Medical Center, Utrecht, the Netherlands

    Abstract

    We adapted a minimal model to assess β-cell function during a hyperglycemic glucose clamp and to uncover peculiar aspects of the relationship among β-cell function, plasma glucose, and insulin sensitivity (IS) in offspring of Caucasian patients with type 2 diabetes (OfT2D). We pooled two data sets of OfT2D (n = 69) and control subjects (n = 45) with normal glucose regulation. Plasma C-peptide was measured during a hyperglycemic clamp (∼10 mmol/l) to quantify model-based first-phase secretion and glucose sensitivity of second-phase secretion (β). IS was quantified during the hyperglycemic clamp. In the pooled data, first-phase secretion was linearly and negatively related to fasting plasma glucose, but not IS; OfT2D lay on a distinct line shifted to the left of the control subjects. In contrast, β was negatively related to IS, and OfT2D lay on a distinct line shifted more and more to the left of the control subjects, as IS was worse. Thus, in OfT2D lower β-cell adaptive responses exist between ambient glycemia and first-phase insulin secretion and between IS and second-phase secretion. Under conditions leading to decreased insulin sensitivity, these disturbed relationships may lead to progression to diabetes in OfT2D.

    Footnotes

    • Address correspondence and reprint requests to Riccardo C. Bonadonna, Division of Endocrinology and Metabolic Diseases, Ospedale Civile Maggiore, Piazzale Stefani 1, 37126 Verona, Italy. E-mail: rcbonado{at}tin.it.

      Received for publication 2 June 2002 and accepted in revised form 11 November 2002.

      BSA, body surface area; CV, coefficient of variation; FDR, first-degree relative; IS, insulin sensitivity; OfT2D, offspring of Caucasian patients with type 2 diabetes; OGTT, oral glucose tolerance test.

    | Table of Contents
    Advertisement